Literature DB >> 16433048

Voriconazole curative treatment for Acremonium species keratitis developed in a patient with concomitant Staphylococcus aureus corneal infection: a case report.

Anna Cretì1, Vincenzo Esposito, Maria Bocchetti, Gianluca Baldi, Pasquale De Rosa, Roberto Parrella, Antonio Chirianni.   

Abstract

The case of a 49-year-old male Caucasian, with more than a 3-year history of recurrent keratoconjunctivitis treated with steroids, antibiotics and midriatics, is reported. A combined Acremonium spp. and S. aureus infection was detected. After unsuccessful therapy with fluconazole, the Acremonium spp. infection was eradicated by voriconazole treatment. To our knowledge, this is the first case report of complete regression of this kind of infection by the use of voriconazole. Therefore, we strongly recommend, in the event of a compatible clinical picture, laboratory testing for mycetes even in the absence of traumatic events, and the use of the new generation azoles, in order avoid a keratoplasty intervention and disease progression to severe endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433048

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

Review 1.  Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis.

Authors:  Shukla Das; Rumpa Saha; Sajad Ahmad Dar; V G Ramachandran
Journal:  Mycopathologia       Date:  2010-06-25       Impact factor: 2.574

2.  Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Authors:  Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2010-06

3.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.